phase1PRMD: Personalized Repeated Measurement Design for Phase I Clinical Trials

Implements Bayesian phase I repeated measurement design that accounts for multidimensional toxicity endpoints and longitudinal efficacy measure from multiple treatment cycles. The package provides flags to fit a variety of model-based phase I design, including 1 stage models with or without individualized dose modification, 3-stage models with or without individualized dose modification, etc. Functions are provided to recommend dosage selection based on the data collected in the available patient cohorts and to simulate trial characteristics given design parameters. Yin, Jun, et al. (2017) <doi:10.1002/sim.7134>.

Version: 1.0.2
Depends: R (≥ 3.0.0), coda (≥ 0.13), ggplot2, stats
Imports: rjags, arrayhelpers, MASS, reshape2, plyr, dplyr, RColorBrewer, gridExtra, kableExtra, knitr
Published: 2020-03-09
Author: Lu Zhang, Jun Yin
Maintainer: Lu Zhang <luzhangstat at gmail.com>
License: GPL-2 | GPL-3 [expanded from: GPL (≥ 2)]
NeedsCompilation: no
SystemRequirements: JAGS (http://mcmc-jags.sourceforge.net)
Materials: README NEWS
CRAN checks: phase1PRMD results

Downloads:

Reference manual: phase1PRMD.pdf
Package source: phase1PRMD_1.0.2.tar.gz
Windows binaries: r-devel: phase1PRMD_1.0.2.zip, r-release: phase1PRMD_1.0.2.zip, r-oldrel: phase1PRMD_1.0.2.zip
macOS binaries: r-release: phase1PRMD_1.0.2.tgz, r-oldrel: phase1PRMD_1.0.2.tgz
Old sources: phase1PRMD archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=phase1PRMD to link to this page.